These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34210824)

  • 1. Impact of Renal Impairment on Intensive Blood-Pressure-Lowering Therapy and Outcomes in Intracerebral Hemorrhage: Results From ATACH-2.
    Fukuda-Doi M; Yamamoto H; Koga M; Doi Y; Qureshi AI; Yoshimura S; Miwa K; Ishigami A; Shiozawa M; Omae K; Ihara M; Toyoda K
    Neurology; 2021 Aug; 97(9):e913-e921. PubMed ID: 34210824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage.
    Zheng D; Sato S; Arima H; Heeley E; Delcourt C; Cao Y; Chalmers J; Anderson CS;
    Am J Kidney Dis; 2016 Jul; 68(1):94-102. PubMed ID: 26948991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White Matter Hyperintensities and Blood Pressure Lowering in Acute Intracerebral Hemorrhage: A Secondary Analysis of the ATACH-2 Trial.
    Morotti A; Shoamanesh A; Oliveira-Filho J; Schlunk F; Romero JM; Jessel M; Ayres A; Vashkevich A; Schwab K; Cassarly C; Martin RH; Greenberg SM; Qureshi AI; Rosand J; Goldstein JN;
    Neurocrit Care; 2020 Feb; 32(1):180-186. PubMed ID: 31218636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional Differences in the Response to Acute Blood Pressure Lowering After Cerebral Hemorrhage.
    Toyoda K; Palesch YY; Koga M; Foster L; Yamamoto H; Yoshimura S; Ihara M; Fukuda-Doi M; Okazaki S; Tanaka K; Miwa K; Hasegawa Y; Shiokawa Y; Iwama T; Kamiyama K; Hoshino H; Steiner T; Yoon BW; Wang Y; Hsu CY; Qureshi AI;
    Neurology; 2021 Feb; 96(5):e740-e751. PubMed ID: 33219136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2.
    Fukuda-Doi M; Yamamoto H; Koga M; Palesch YY; Durkalski-Mauldin VL; Qureshi AI; Yoshimura S; Okazaki S; Miwa K; Okada Y; Ueda T; Okuda S; Nakahara J; Suzuki N; Toyoda K
    Stroke; 2020 Aug; 51(8):2282-2286. PubMed ID: 32623977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial.
    Morotti A; Brouwers HB; Romero JM; Jessel MJ; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Greenberg SM; Martin RH; Qureshi AI; Rosand J; Goldstein JN;
    JAMA Neurol; 2017 Aug; 74(8):950-960. PubMed ID: 28628707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral Microbleeds and the Effect of Intensive Blood Pressure Reduction on Hematoma Expansion and Functional Outcomes: A Secondary Analysis of the ATACH-2 Randomized Clinical Trial.
    Shoamanesh A; Morotti A; Romero JM; Oliveira-Filho J; Schlunk F; Jessel MJ; Ayres AM; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Martin RH; Qureshi AI; Greenberg SM; Rosand J; Goldstein JN;
    JAMA Neurol; 2018 Jul; 75(7):850-859. PubMed ID: 29710119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive Blood Pressure Lowering in Patients with Moderate to Severe Grade Acute Cerebral Hemorrhage: Post Hoc Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-2 Trial.
    Qureshi AI; Foster LD; Lobanova I; Huang W; Suarez JI
    Cerebrovasc Dis; 2020; 49(3):244-252. PubMed ID: 32585668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive Blood Pressure Lowering and DWI Lesions in Intracerebral Hemorrhage: Exploratory Analysis of the ATACH-2 Randomized Trial.
    Shoamanesh A; Cassarly C; Morotti A; Romero JM; Oliveira-Filho J; Schlunk F; Jessel M; Butcher K; Gioia L; Ayres A; Vashkevich A; Schwab K; Afzal MR; Martin RH; Qureshi AI; Greenberg SM; Rosand J; Goldstein JN;
    Neurocrit Care; 2022 Feb; 36(1):71-81. PubMed ID: 34292474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale.
    Qureshi AI; Palesch YY
    Neurocrit Care; 2011 Dec; 15(3):559-76. PubMed ID: 21626077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Trajectory of Systolic Blood Pressure and Outcomes in Acute Intracerebral Hemorrhage: ATACH-2 Trial Cohort.
    Tanaka K; Koga M; Fukuda-Doi M; Qureshi AI; Yamamoto H; Miwa K; Ihara M; Toyoda K;
    Stroke; 2022 Jun; 53(6):1854-1862. PubMed ID: 35400202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical analysis plan for pooled individual patient data from two landmark randomized trials (INTERACT2 and ATACH-II) of intensive blood pressure lowering treatment in acute intracerebral hemorrhage.
    Moullaali TJ; Wang X; Martin RH; Shipes VB; Qureshi AI; Anderson CS; Palesch YY
    Int J Stroke; 2019 Apr; 14(3):321-328. PubMed ID: 30418098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High Initial Systolic Blood Pressure: Post Hoc Analysis of a Randomized Clinical Trial.
    Qureshi AI; Huang W; Lobanova I; Barsan WG; Hanley DF; Hsu CY; Lin CL; Silbergleit R; Steiner T; Suarez JI; Toyoda K; Yamamoto H;
    JAMA Neurol; 2020 Nov; 77(11):1355-1365. PubMed ID: 32897310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial.
    Peralta CA; McClure LA; Scherzer R; Odden MC; White CL; Shlipak M; Benavente O; Pergola P
    Circulation; 2016 Feb; 133(6):584-91. PubMed ID: 26762524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage.
    Qureshi AI; Palesch YY; Barsan WG; Hanley DF; Hsu CY; Martin RL; Moy CS; Silbergleit R; Steiner T; Suarez JI; Toyoda K; Wang Y; Yamamoto H; Yoon BW;
    N Engl J Med; 2016 Sep; 375(11):1033-43. PubMed ID: 27276234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood Pressure-Attained Analysis of ATACH 2 Trial.
    Qureshi AI; Palesch YY; Foster LD; Barsan WG; Goldstein JN; Hanley DF; Hsu CY; Moy CS; Qureshi MH; Silbergleit R; Suarez JI; Toyoda K; Yamamoto H;
    Stroke; 2018 Jun; 49(6):1412-1418. PubMed ID: 29789395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial Estimated Glomerular Filtration Rate Decline and Long-Term Renal Function During Intensive Antihypertensive Therapy: A Post Hoc Analysis of the SPRINT and ACCORD-BP Randomized Controlled Trials.
    Collard D; Brouwer TF; Olde Engberink RHG; Zwinderman AH; Vogt L; van den Born BH
    Hypertension; 2020 May; 75(5):1205-1212. PubMed ID: 32223381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medical therapy for intracranial hemorrhage: update blood pressure management for prevention and acute treatment].
    Koga M; Toyoda K
    Rinsho Shinkeigaku; 2012; 52(11):1110-2. PubMed ID: 23196532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage.
    Leasure AC; Qureshi AI; Murthy SB; Kamel H; Goldstein JN; Walsh KB; Woo D; Shi FD; Huttner HB; Ziai WC; Hanley DF; Matouk CC; Sansing LH; Falcone GJ; Sheth KN
    Stroke; 2019 Aug; 50(8):2016-2022. PubMed ID: 31272326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion.
    Morotti A; Boulouis G; Romero JM; Brouwers HB; Jessel MJ; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Greenberg SM; Martin RH; Qureshi AI; Rosand J; Goldstein JN;
    Neurology; 2017 Aug; 89(6):548-554. PubMed ID: 28701501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.